(Q34346795)

1 August 2017

1 reference

title

Farnesyl protein transferase inhibitors as targeted therapies for hematologic malignancies (English)

1 reference

1 August 2017

J E Karp

1

1 reference

1 August 2017

publication date

1 July 2001

1 reference

1 August 2017

published in

Seminars in Hematology

1 reference

1 August 2017

volume

38

1 reference

1 August 2017

issue

3 Suppl 7

1 reference

1 August 2017

page(s)

16-23

1 reference

Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990126-X

7 January 2021

Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990126-X

7 January 2021

RAS and leukemia: from basic mechanisms to gene-directed therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990126-X

7 January 2021

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990126-X

7 January 2021

Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990126-X

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990126-X

7 January 2021

Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0037-1963%2801%2990126-X

7 January 2021

10.1016/S0037-1963(01)90126-X

Identifiers

DOI

1 reference

1 August 2017

1 reference